#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Brain stem glioma Richter's syndrome Waldenstrom's macroglobulinaemia refractory Osteosarcoma metastatic Thalassaemia beta Brain abscess Sexually transmitted disease Glycogen storage disease type II Retinitis pigmentosa Chronic graft versus host disease in liver Urea cycle disorder Neutropenia Neonatal alloimmune thrombocytopenia Adenocarcinoma pancreas More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Life with Disease Adrenogenital syndrome Waldenstrom’s macroglobulinaemia refractory – Diagnostics Synovial sarcoma recurrent – Diagnostics Mastocytosis – Life with Disease Usher’s syndrome Angiosarcoma recurrent Mantle cell lymphoma stage IV – Diagnostics Malignant fibrous histiocytoma – Treatment Lennox-Gastaut syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Phenol Midazolam Wt1 Lamp Mrna Dc Difelikefalin Gsk3739937 Oteracil GSKVX000000030810 Hydrocortisone Acetate Izaflortaucipir (18F) Dl-Alpha Tocopherol Acetate Venlafaxine Hydrochloride Lumasiran Metoprolol Succinate Tulmimetostat BGB-16673 Sebetralstat Dacarbazine Citrate LUMC-BOB1-B7-TCR.1 Alternaria Alternata Extract VG801-2 More therapies…

    Learn about Your Condition

    Primary hypogonadism Metastatic gastric cancer Choroid melanoma Lung adenocarcinoma Stress cardiomyopathy Cholangitis sclerosing Lung adenocarcinoma stage IV Prolymphocytic leukaemia Fallopian tube cancer Cold type haemolytic anaemia Acarodermatitis Renal cancer metastatic Neuroendocrine tumour Cardiac failure congestive Spondylolisthesis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier de Grasse

Centre Hospitalier de Grasse

Chemin de Clavary, Grasse, 06130, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Cefepime
    • Daptomycin
    • Piperacillin
    France

  • Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France

  • Study on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!